Toxicity and outcome results of RTOG 9311: A phase I–II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non–small-cell lung carcinoma

Three Dimensional ◽

Conformal Radiotherapy ◽

Small Cell ◽

Small Cell Lung ◽

Dose Escalation Study ◽

Cell Lung Carcinoma ◽

9013 POSTER DISCUSSION Phase I Dose-escalation Study of AXL1717: a Novel Targeted Oral Insulin-like Growth Factor-1 Receptor (IGF-1R) Inhibitor and Its Implications for Patients With Non-small Cell Lung Carcinoma

European Journal of Cancer ◽

10.1016/s0959-8049(11)72325-5 ◽

2011 ◽

Vol 47 ◽

pp. S595-S596 ◽

Cited By ~ 1

Author(s):

S. Ekman ◽

J. Harmenberg ◽

B. Stáhl ◽

A. Hedlund ◽

S. Bergström ◽

...

Keyword(s):

Growth Factor ◽

Phase I ◽

Lung Carcinoma ◽

Dose Escalation ◽

Small Cell ◽

Oral Insulin ◽

Small Cell Lung ◽

Dose Escalation Study ◽

Cell Lung Carcinoma

A phase I dose-escalation study using three-dimensional conformal radiotherapy with concurrent cisplatin and S-1 in patients with stage III non-small cell lung cancer.

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.7086 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. 7086-7086

Author(s):

T. Kozuka ◽

H. Harada ◽

M. Nishio ◽

H. Murakami ◽

F. Ohyanagi ◽

...

Keyword(s):

Lung Cancer ◽

Phase I ◽

Small Cell Lung Cancer ◽

Dose Escalation ◽

Three Dimensional ◽

Conformal Radiotherapy ◽

Small Cell ◽

Small Cell Lung ◽

Dose Escalation Study ◽

A Phase I Dose Escalation Study using Three-dimensional Conformal Radiotherapy with Concurrent Cisplatin and S-1 in Patients with Stage III Non–small Cell Lung Cancer

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2009.07.1080 ◽

2009 ◽

Vol 75 (3) ◽

pp. S473-S474

Author(s):

T. Kozuka ◽

H. Harada ◽

M. Nishio ◽

H. Murakami ◽

F. Ohyanagi ◽

...

Keyword(s):

Lung Cancer ◽

Phase I ◽

Small Cell Lung Cancer ◽

Dose Escalation ◽

Three Dimensional ◽

Conformal Radiotherapy ◽

Small Cell ◽

Small Cell Lung ◽

Dose Escalation Study ◽

Results of a phase I dose-escalation study using three-dimensional conformal radiotherapy in the treatment of inoperable nonsmall cell lung carcinoma

Cancer ◽

10.1002/cncr.21007 ◽

2005 ◽

Vol 103 (10) ◽

pp. 2118-2127 ◽

Cited By ~ 152

Author(s):

Kenneth E. Rosenzweig ◽

Jana L. Fox ◽

Ellen Yorke ◽

Howard Amols ◽

Andrew Jackson ◽

...

Keyword(s):

Phase I ◽

Lung Carcinoma ◽

Dose Escalation ◽

Three Dimensional ◽

Conformal Radiotherapy ◽

Dose Escalation Study ◽

Cell Lung Carcinoma ◽

Nonsmall Cell Lung Carcinoma ◽

A novel oral insulin-like growth factor-1 receptor pathway modulator and its implications for patients with non-small cell lung carcinoma: A phase I clinical trial

Acta Oncologica ◽

10.3109/0284186x.2015.1049290 ◽

2015 ◽

Vol 55 (2) ◽

pp. 140-148 ◽

Cited By ~ 5

Author(s):

Simon Ekman ◽

Johan Harmenberg ◽

Jan-Erik Frödin ◽

Stefan Bergström ◽

Cecilia Wassberg ◽

...

Keyword(s):

Clinical Trial ◽

Growth Factor ◽

Phase I ◽

Lung Carcinoma ◽

Small Cell ◽

Oral Insulin ◽

Insulin Like Growth Factor ◽

Small Cell Lung ◽

Cell Lung Carcinoma

Dose-escalation study of chemoradiotherapy of three-dimensional conformal radiotherapy (3D-CRT) with accelerated hyperfractionation (AHF) and concurrent chemotherapy (cisplatin and vinorelbine) for unresectable stage III non-small cell lung cancer (NSCLC).

Journal of Clinical Oncology ◽

10.1200/jco.2011.29.15_suppl.e17518 ◽

2011 ◽

Vol 29 (15_suppl) ◽

pp. e17518-e17518

Author(s):

N. Yoshimura ◽

S. Kudoh ◽

H. Tanaka ◽

N. Sizumira ◽

T. Kimura ◽

...

Keyword(s):

Lung Cancer ◽

Three Dimensional ◽

Conformal Radiotherapy ◽

Concurrent Chemotherapy ◽

Small Cell ◽

Small Cell Lung ◽

Dose Escalation Study ◽

Unresectable Stage ◽

Three Dimensional Conformal Radiotherapy ◽

3D Crt

Clinical Phase I study with an Insulin-like Growth Factor-1 Receptor Inhibitor: Experiences in patients with squamous non-small cell lung carcinoma

Acta Oncologica ◽

10.3109/0284186x.2010.499370 ◽

2010 ◽

Vol 50 (3) ◽

pp. 441-447 ◽

Cited By ~ 34

Author(s):

Simon Ekman ◽

Jan-Erik Frödin ◽

Johan Harmenberg ◽

Antonina Bergman ◽

Åsa Hedlund ◽

...

Keyword(s):

Growth Factor ◽

Phase I ◽

Lung Carcinoma ◽

Phase I Study ◽

Small Cell ◽

Small Cell Lung ◽

Cell Lung Carcinoma ◽

Clinical Phase ◽

Receptor Inhibitor

Phase I Study of Concurrent High-Dose Three-Dimensional Conformal Radiotherapy With Chemotherapy Using Cisplatin and Vinorelbine for Unresectable Stage III Non-Small-Cell Lung Cancer

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2011.01.008 ◽

2012 ◽

Vol 82 (2) ◽

pp. 953-959 ◽

Cited By ~ 6

Author(s):

Ikuo Sekine ◽

Minako Sumi ◽

Yoshinori Ito ◽

Hidehito Horinouchi ◽

Hiroshi Nokihara ◽

...

Keyword(s):

Lung Cancer ◽

Phase I ◽

Phase I Study ◽

Three Dimensional ◽

Conformal Radiotherapy ◽

Small Cell ◽

High Dose ◽

Small Cell Lung ◽

Unresectable Stage ◽

Phase I Study With Dose Escalation of Gemcitabine and Cisplatin in Combination With Ifosfamide (GIP) in Patients With Non???Small-Cell Lung Carcinoma

American Journal of Clinical Oncology ◽

10.1097/01.coc.0000046580.51486.ff ◽

2004 ◽

Vol 27 (1) ◽

pp. 89-95 ◽

Cited By ~ 5

Author(s):

Hugues Bourgeois ◽

Isabelle Billiart ◽

Virginie Chabrun ◽

St??phanie Chieze ◽

David Lemerre ◽

...

Keyword(s):

Phase I ◽

Lung Carcinoma ◽

Dose Escalation ◽

Phase I Study ◽

Small Cell ◽

Small Cell Lung ◽

Cell Lung Carcinoma ◽

Gemcitabine And Cisplatin

Phase I study of irinotecan (CPT-11), cisplatin (cDDP) and radical thoracic radiation (TRT) in the treatment of locally advanced non-small cell lung carcinoma (NSCLC)

Lung Cancer ◽

10.1016/s0169-5002(00)80335-9 ◽

2000 ◽

Vol 29 (1) ◽

pp. 102 ◽

Cited By ~ 2

Author(s):

C Langer ◽

B Movsas ◽

C Huang ◽

M Millenson ◽

C Maiale ◽

...

Keyword(s):

Phase I ◽

Lung Carcinoma ◽

Phase I Study ◽

Locally Advanced ◽

Small Cell ◽

Small Cell Lung ◽

Cell Lung Carcinoma ◽

Thoracic Radiation